Vista Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 10.04 million. Revenue was INR 12.89 million compared to INR 2.99 million a year ago. Net loss was INR 38.68 million compared to net income of INR 20.52 million a year ago. Basic loss per share from continuing operations was INR 1.05 compared to basic earnings per share from continuing operations of INR 0.56 a year ago.
For the full year, sales was INR 10.04 million compared to INR 3.95 million a year ago. Revenue was INR 12.89 million compared to INR 5.6 million a year ago. Net loss was INR 58.17 million compared to INR 8.89 million a year ago. Basic loss per share from continuing operations was INR 1.58 compared to INR 0.24 a year ago.